Literature DB >> 5909697

Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.

J Fielding, M C O'Shaughnessy, G M Brunström.   

Abstract

The differential ferrioxamine test measures the amount of body iron as ferrioxamine (Fv) chelated by a standard dose of desferrioxamine.Five patients with untreated, uncomplicated idiopathic haemochromatosis and one with transfusion haemosiderosis gave Fv in the range 1,948 to 2,462 mug./kg. (normal 110 to 500). One case of transfusion haemochromatosis with haemolytic anaemia and renal failure gave an Fv value of 8,019 mug./kg. Four patients with idiopathic haemochromatosis after therapeutic venesection gave Fv values of 212 to 885 mug./kg. One relative with a value for Fv of 776 mug./kg. was shown to have early cirrhosis by liver biopsy. Serial Fv measurement after venesection in this patient provided a preliminary assessment of the relationship between Fv values and available iron stores up to about 2,000 mg. iron. This relationship applies only when red cell survival is normal. Approximate figures for the range of available storage iron in 31 healthy men are deduced, namely, 200 mg. to 1,000 mg. (3 to 14 mg./kg.). The test should prove useful in the diagnosis of iron overload, in the screening of relatives for early haemochromatosis, and in the management of iron storage diseases.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5909697      PMCID: PMC473220          DOI: 10.1136/jcp.19.2.159

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID.

Authors:  H M LLOYD; L W POWELL; M J THOMAS
Journal:  Lancet       Date:  1964-09-12       Impact factor: 79.321

2.  THE RATE OF IRON ACCUMULATION IN IRON STORAGE DISEASE.

Authors:  W H CROSBY; M E CONRAD; M S WHEBY
Journal:  Blood       Date:  1963-10       Impact factor: 22.113

3.  THE USE OF DTPA IN THE DIAGNOSIS AND MANAGEMENT OF IDIOPATHIC HAEMOCHROMATOSIS.

Authors:  R J WALSH; K W PERKINS; C R BLACKBURN; R SANFORD; S CANTRILL
Journal:  Australas Ann Med       Date:  1963-08

4.  Management of familial hemochromatosis.

Authors:  W G FREY; J MILNE; G B JOHNSON; F G EBAUGH
Journal:  N Engl J Med       Date:  1961-07-06       Impact factor: 91.245

5.  Serum iron determination.

Authors:  D KOK; F WILD
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

6.  The determination of the total iron-binding capacity of serum.

Authors:  W N RAMSAY
Journal:  Clin Chim Acta       Date:  1957-06       Impact factor: 3.786

7.  Effect of Desferrioxamine and D.T.P.A. in Iron Overload.

Authors:  R M Bannerman; S T Callender; D L Williams
Journal:  Br Med J       Date:  1962-12-15

8.  Hepatic pathology in relatives of patients with haemochromatosis.

Authors:  P J SCHEUER; R WILLIAMS; A R MUIR
Journal:  J Pathol Bacteriol       Date:  1962-07

9.  Iron metabolism; iron stores in man as measured by phlebotomy.

Authors:  D HASKINS; A R STEVENS; S FINCH; C A FINCH
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

10.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889

View more
  5 in total

1.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  Idiopathic hemochromatosis. II. Diagnosis and treatment.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-06-24       Impact factor: 8.262

3.  Idiopathic Haemochromatosis.

Authors: 
Journal:  Br Med J       Date:  1967-02-25

4.  Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.

Authors:  L W Powell; M J Thomas
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

5.  Iron chelation in haematomas at fracture sites.

Authors:  M C O'Shaughnessy; G M Brunström; J Fielding
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.